Pre-order Enquiry
Request Free Sample
Global Acute Migraine Medications Market Insights and Forecast to 2027
SKU ID : QYR-18222705 | Publishing Date : 10-May-2021 | No. of pages : 117
Detailed TOC of Global Acute Migraine Medications Market Insights and Forecast to 2027
1 Study Coverage1.1 Acute Migraine Medications Product Introduction
1.2 Market by Type
1.2.1 Global Acute Migraine Medications Market Size Growth Rate by Type
1.4.2 Triptans
1.4.3 NSAIDs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Acute Migraine Medications Market Size Growth Rate by Application
1.3.2 Drug Stores
1.3.3 Hospital Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Acute Migraine Medications Sales Estimates and Forecasts 2016-2027
2.2 Global Acute Migraine Medications Revenue Estimates and Forecasts 2016-2027
2.3 Global Acute Migraine Medications Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Acute Migraine Medications Regions by Sales
2.4.1 Global Top Acute Migraine Medications Regions by Sales (2016-2021)
2.4.2 Global Top Acute Migraine Medications Regions by Sales (2022-2027)
2.5 Global Top Acute Migraine Medications Regions by Revenue
2.5.1 Global Top Acute Migraine Medications Regions by Revenue (2016-2021)
2.5.2 Global Top Acute Migraine Medications Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Acute Migraine Medications Sales by Manufacturers
3.1.1 Global Top Acute Migraine Medications Manufacturers by Sales (2016-2021)
3.1.2 Global Top Acute Migraine Medications Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Acute Migraine Medications Sales in 2020
3.2 Global Acute Migraine Medications Revenue by Manufacturers
3.2.1 Global Top Acute Migraine Medications Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Acute Migraine Medications Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Acute Migraine Medications Revenue in 2020
3.3 Global Acute Migraine Medications Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Acute Migraine Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Acute Migraine Medications Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Acute Migraine Medications Sales by Type
4.1.1 Global Acute Migraine Medications Historical Sales by Type (2016-2021)
4.1.2 Global Acute Migraine Medications Forecasted Sales by Type (2022-2027)
4.1.3 Global Acute Migraine Medications Sales Market Share by Type (2016-2027)
4.2 Global Acute Migraine Medications Revenue by Type
4.2.1 Global Acute Migraine Medications Historical Revenue by Type (2016-2021)
4.2.2 Global Acute Migraine Medications Forecasted Revenue by Type (2022-2027)
4.2.3 Global Acute Migraine Medications Revenue Market Share by Type (2016-2027)
4.3 Global Acute Migraine Medications Price by Type
4.3.1 Global Acute Migraine Medications Price by Type (2016-2021)
4.3.2 Global Acute Migraine Medications Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Acute Migraine Medications Sales by Application
5.1.1 Global Acute Migraine Medications Historical Sales by Application (2016-2021)
5.1.2 Global Acute Migraine Medications Forecasted Sales by Application (2022-2027)
5.1.3 Global Acute Migraine Medications Sales Market Share by Application (2016-2027)
5.2 Global Acute Migraine Medications Revenue by Application
5.2.1 Global Acute Migraine Medications Historical Revenue by Application (2016-2021)
5.2.2 Global Acute Migraine Medications Forecasted Revenue by Application (2022-2027)
5.2.3 Global Acute Migraine Medications Revenue Market Share by Application (2016-2027)
5.3 Global Acute Migraine Medications Price by Application
5.3.1 Global Acute Migraine Medications Price by Application (2016-2021)
5.3.2 Global Acute Migraine Medications Price Forecast by Application (2022-2027)
6 North America
6.1 North America Acute Migraine Medications Market Size by Type
6.1.1 North America Acute Migraine Medications Sales by Type (2016-2027)
6.1.2 North America Acute Migraine Medications Revenue by Type (2016-2027)
6.2 North America Acute Migraine Medications Market Size by Application
6.2.1 North America Acute Migraine Medications Sales by Application (2016-2027)
6.2.2 North America Acute Migraine Medications Revenue by Application (2016-2027)
6.3 North America Acute Migraine Medications Market Size by Country
6.3.1 North America Acute Migraine Medications Sales by Country (2016-2027)
6.3.2 North America Acute Migraine Medications Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Acute Migraine Medications Market Size by Type
7.1.1 Europe Acute Migraine Medications Sales by Type (2017-2027)
7.1.2 Europe Acute Migraine Medications Revenue by Type (2017-2027)
7.2 Europe Acute Migraine Medications Market Size by Application
7.2.1 Europe Acute Migraine Medications Sales by Application (2017-2027)
7.2.2 Europe Acute Migraine Medications Revenue by Application (2017-2027)
7.3 Europe Acute Migraine Medications Market Size by Country
7.3.1 Europe Acute Migraine Medications Sales by Country (2017-2027)
7.3.2 Europe Acute Migraine Medications Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Acute Migraine Medications Market Size by Type
8.1.1 Asia Pacific Acute Migraine Medications Sales by Type (2018-2027)
8.1.2 Asia Pacific Acute Migraine Medications Revenue by Type (2018-2027)
8.2 Asia Pacific Acute Migraine Medications Market Size by Application
8.2.1 Asia Pacific Acute Migraine Medications Sales by Application (2018-2027)
8.2.2 Asia Pacific Acute Migraine Medications Revenue by Application (2018-2027)
8.3 Asia Pacific Acute Migraine Medications Market Size by Region
8.3.1 Asia Pacific Acute Migraine Medications Sales by Region (2018-2027)
8.3.2 Asia Pacific Acute Migraine Medications Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Acute Migraine Medications Market Size by Type
9.1.1 Latin America Acute Migraine Medications Sales by Type (2019-2027)
9.1.2 Latin America Acute Migraine Medications Revenue by Type (2019-2027)
9.2 Latin America Acute Migraine Medications Market Size by Application
9.2.1 Latin America Acute Migraine Medications Sales by Application (2019-2027)
9.2.2 Latin America Acute Migraine Medications Revenue by Application (2019-2027)
9.3 Latin America Acute Migraine Medications Market Size by Country
9.3.1 Latin America Acute Migraine Medications Sales by Country (2019-2027)
9.3.2 Latin America Acute Migraine Medications Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Acute Migraine Medications Market Size by Type
6.1.1 Middle East and Africa Acute Migraine Medications Sales by Type (2016-2027)
6.1.2 Middle East and Africa Acute Migraine Medications Revenue by Type (2016-2027)
6.2 Middle East and Africa Acute Migraine Medications Market Size by Application
6.2.1 Middle East and Africa Acute Migraine Medications Sales by Application (2016-2027)
6.2.2 Middle East and Africa Acute Migraine Medications Revenue by Application (2016-2027)
6.3 Middle East and Africa Acute Migraine Medications Market Size by Country
6.3.1 Middle East and Africa Acute Migraine Medications Sales by Country (2016-2027)
6.3.2 Middle East and Africa Acute Migraine Medications Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 UAE
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Acute Migraine Medications Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 GSK Acute Migraine Medications Product Description
11.1.5 GSK Related Developments
11.2 Teva
11.2.1 Teva Corporation Information
11.2.2 Teva Overview
11.2.3 Teva Acute Migraine Medications Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Teva Acute Migraine Medications Product Description
11.2.5 Teva Related Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Acute Migraine Medications Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Pfizer Acute Migraine Medications Product Description
11.3.5 Pfizer Related Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Overview
11.4.3 Novartis Acute Migraine Medications Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Novartis Acute Migraine Medications Product Description
11.4.5 Novartis Related Developments
11.5 Merck
11.5.1 Merck Corporation Information
11.5.2 Merck Overview
11.5.3 Merck Acute Migraine Medications Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Merck Acute Migraine Medications Product Description
11.5.5 Merck Related Developments
11.6 Sun Pharma
11.6.1 Sun Pharma Corporation Information
11.6.2 Sun Pharma Overview
11.6.3 Sun Pharma Acute Migraine Medications Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Sun Pharma Acute Migraine Medications Product Description
11.6.5 Sun Pharma Related Developments
11.7 Grunenthal
11.7.1 Grunenthal Corporation Information
11.7.2 Grunenthal Overview
11.7.3 Grunenthal Acute Migraine Medications Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Grunenthal Acute Migraine Medications Product Description
11.7.5 Grunenthal Related Developments
11.8 Endo Pharmaceuticals
11.8.1 Endo Pharmaceuticals Corporation Information
11.8.2 Endo Pharmaceuticals Overview
11.8.3 Endo Pharmaceuticals Acute Migraine Medications Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Endo Pharmaceuticals Acute Migraine Medications Product Description
11.8.5 Endo Pharmaceuticals Related Developments
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Acute Migraine Medications Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 GSK Acute Migraine Medications Product Description
11.1.5 GSK Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Acute Migraine Medications Value Chain Analysis
12.2 Acute Migraine Medications Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Acute Migraine Medications Production Mode & Process
12.4 Acute Migraine Medications Sales and Marketing
12.4.1 Acute Migraine Medications Sales Channels
12.4.2 Acute Migraine Medications Distributors
12.5 Acute Migraine Medications Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Acute Migraine Medications Industry Trends
13.2 Acute Migraine Medications Market Drivers
13.3 Acute Migraine Medications Market Challenges
13.4 Acute Migraine Medications Market Restraints
14 Key Findings in The Global Acute Migraine Medications Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Figures, Tables and Charts Available in Global Acute Migraine Medications Market Insights and Forecast to 2027
List of TablesTable 1. Global Acute Migraine Medications Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Triptans
Table 3. Major Manufacturers of NSAIDs
Table 4. Major Manufacturers of Others
Table 5. Global Acute Migraine Medications Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Acute Migraine Medications Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Acute Migraine Medications Sales by Region (2016-2021) & (K Units)
Table 8. Global Acute Migraine Medications Sales Market Share by Region (2016-2021)
Table 9. Global Acute Migraine Medications Sales by Region (2016-2021) & (K Units)
Table 10. Global Acute Migraine Medications Sales Market Share by Region (2022-2027)
Table 11. Global Acute Migraine Medications Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Acute Migraine Medications Revenue Market Share by Region (2016-2021)
Table 13. Global Acute Migraine Medications Revenue by Region (2022-2027) & (US$ Million)
Table 14. Global Acute Migraine Medications Revenue Market Share by Region (2022-2027)
Table 15. Global Acute Migraine Medications Sales by Manufacturers (2016-2021) & (K Units)
Table 16. Global Acute Migraine Medications Sales Share by Manufacturers (2016-2021)
Table 17. Global Acute Migraine Medications Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 18. Global Acute Migraine Medications Revenue Share by Manufacturers (2016-2021)
Table 19. Acute Migraine Medications Price by Manufacturers 2016-2021 (US$/Unit)
Table 20. Global Acute Migraine Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Acute Migraine Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Migraine Medications as of 2020)
Table 22. Acute Migraine Medications Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Acute Migraine Medications Product Offered
Table 24. Date of Manufacturers Enter into Acute Migraine Medications Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Acute Migraine Medications Sales by Type (2016-2021) & (K Units)
Table 27. Global Acute Migraine Medications Sales by Type (2022-2027) & (K Units)
Table 28. Global Acute Migraine Medications Sales Share by Type (2016-2021)
Table 29. Global Acute Migraine Medications Sales Share by Type (2022-2027)
Table 30. Global Acute Migraine Medications Revenue by Type (2016-2021) & (US$ Million)
Table 31. Global Acute Migraine Medications Revenue by Type (2022-2027) & (US$ Million)
Table 32. Global Acute Migraine Medications Revenue Share by Type (2016-2021)
Table 33. Global Acute Migraine Medications Revenue Share by Type (2022-2027)
Table 34. Acute Migraine Medications Price by Type (2016-2021) & (US$/Unit)
Table 35. Global Acute Migraine Medications Price Forecast by Type (2022-2027) & (US$/Unit)
Table 36. Global Acute Migraine Medications Sales by Application (2016-2021) & (K Units)
Table 37. Global Acute Migraine Medications Sales by Application (2022-2027) & (K Units)
Table 38. Global Acute Migraine Medications Sales Share by Application (2016-2021)
Table 39. Global Acute Migraine Medications Sales Share by Application (2022-2027)
Table 40. Global Acute Migraine Medications Revenue by Application (2016-2021) & (US$ Million)
Table 41. Global Acute Migraine Medications Revenue by Application (2022-2027) & (US$ Million)
Table 42. Global Acute Migraine Medications Revenue Share by Application (2016-2021)
Table 43. Global Acute Migraine Medications Revenue Share by Application (2022-2027)
Table 44. Acute Migraine Medications Price by Application (2016-2021) & (US$/Unit)
Table 45. Global Acute Migraine Medications Price Forecast by Application (2022-2027) & (US$/Unit)
Table 46. North America Acute Migraine Medications Sales by Type (2016-2021) & (K Units)
Table 47. North America Acute Migraine Medications Sales by Type (2022-2027) & (K Units)
Table 48. North America Acute Migraine Medications Revenue by Type (2016-2021) & (US$ Million)
Table 49. North America Acute Migraine Medications Revenue by Type (2022-2027) & (US$ Million)
Table 50. North America Acute Migraine Medications Sales by Application (2016-2021) & (K Units)
Table 51. North America Acute Migraine Medications Sales by Application (2022-2027) & (K Units)
Table 52. North America Acute Migraine Medications Revenue by Application (2016-2021) & (US$ Million)
Table 53. North America Acute Migraine Medications Revenue by Application (2022-2027) & (US$ Million)
Table 54. North America Acute Migraine Medications Sales by Country (2016-2021) & (K Units)
Table 55. North America Acute Migraine Medications Sales by Country (2022-2027) & (K Units)
Table 56. North America Acute Migraine Medications Revenue by Country (2016-2021) & (US$ Million)
Table 57. North America Acute Migraine Medications Revenue by Country (2022-2027) & (US$ Million)
Table 58. Europe Acute Migraine Medications Sales by Type (2016-2021) & (K Units)
Table 59. Europe Acute Migraine Medications Sales by Type (2022-2027) & (K Units)
Table 60. Europe Acute Migraine Medications Revenue by Type (2016-2021) & (US$ Million)
Table 61. Europe Acute Migraine Medications Revenue by Type (2022-2027) & (US$ Million)
Table 62. Europe Acute Migraine Medications Sales by Application (2016-2021) & (K Units)
Table 63. Europe Acute Migraine Medications Sales by Application (2022-2027) & (K Units)
Table 64. Europe Acute Migraine Medications Revenue by Application (2016-2021) & (US$ Million)
Table 65. Europe Acute Migraine Medications Revenue by Application (2022-2027) & (US$ Million)
Table 66. Europe Acute Migraine Medications Sales by Country (2016-2021) & (K Units)
Table 67. Europe Acute Migraine Medications Sales by Country (2022-2027) & (K Units)
Table 68. Europe Acute Migraine Medications Revenue by Country (2016-2021) & (US$ Million)
Table 69. Europe Acute Migraine Medications Revenue by Country (2022-2027) & (US$ Million)
Table 70. Asia Pacific Acute Migraine Medications Sales by Type (2016-2021) & (K Units)
Table 71. Asia Pacific Acute Migraine Medications Sales by Type (2022-2027) & (K Units)
Table 72. Asia Pacific Acute Migraine Medications Revenue by Type (2016-2021) & (US$ Million)
Table 73. Asia Pacific Acute Migraine Medications Revenue by Type (2022-2027) & (US$ Million)
Table 74. Asia Pacific Acute Migraine Medications Sales by Application (2016-2021) & (K Units)
Table 75. Asia Pacific Acute Migraine Medications Sales by Application (2022-2027) & (K Units)
Table 76. Asia Pacific Acute Migraine Medications Revenue by Application (2016-2021) & (US$ Million)
Table 77. Asia Pacific Acute Migraine Medications Revenue by Application (2022-2027) & (US$ Million)
Table 78. Asia Pacific Acute Migraine Medications Sales by Region (2016-2021) & (K Units)
Table 79. Asia Pacific Acute Migraine Medications Sales by Region (2022-2027) & (K Units)
Table 80. Asia Pacific Acute Migraine Medications Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Acute Migraine Medications Revenue by Region (2022-2027) & (US$ Million)
Table 82. Latin America Acute Migraine Medications Sales by Type (2016-2021) & (K Units)
Table 83. Latin America Acute Migraine Medications Sales by Type (2022-2027) & (K Units)
Table 84. Latin America Acute Migraine Medications Revenue by Type (2016-2021) & (US$ Million)
Table 85. Latin America Acute Migraine Medications Revenue by Type (2022-2027) & (US$ Million)
Table 86. Latin America Acute Migraine Medications Sales by Application (2016-2021) & (K Units)
Table 87. Latin America Acute Migraine Medications Sales by Application (2022-2027) & (K Units)
Table 88. Latin America Acute Migraine Medications Revenue by Application (2016-2021) & (US$ Million)
Table 89. Latin America Acute Migraine Medications Revenue by Application (2022-2027) & (US$ Million)
Table 90. Latin America Acute Migraine Medications Sales by Country (2016-2021) & (K Units)
Table 91. Latin America Acute Migraine Medications Sales by Country (2022-2027) & (K Units)
Table 92. Latin America Acute Migraine Medications Revenue by Country (2016-2021) & (US$ Million)
Table 93. Latin America Acute Migraine Medications Revenue by Country (2022-2027) & (US$ Million)
Table 94. Middle East and Africa Acute Migraine Medications Sales by Type (2016-2021) & (K Units)
Table 95. Middle East and Africa Acute Migraine Medications Sales by Type (2022-2027) & (K Units)
Table 96. Middle East and Africa Acute Migraine Medications Revenue by Type (2016-2021) & (US$ Million)
Table 97. Middle East and Africa Acute Migraine Medications Revenue by Type (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Acute Migraine Medications Sales by Application (2016-2021) & (K Units)
Table 99. Middle East and Africa Acute Migraine Medications Sales by Application (2022-2027) & (K Units)
Table 100. Middle East and Africa Acute Migraine Medications Revenue by Application (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Acute Migraine Medications Revenue by Application (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Acute Migraine Medications Sales by Country (2016-2021) & (K Units)
Table 103. Middle East and Africa Acute Migraine Medications Sales by Country (2022-2027) & (K Units)
Table 104. Middle East and Africa Acute Migraine Medications Revenue by Country (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Acute Migraine Medications Revenue by Country (2022-2027) & (US$ Million)
Table 106. GSK Corporation Information
Table 107. GSK Description and Major Businesses
Table 108. GSK Acute Migraine Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 109. GSK Acute Migraine Medications Product
Table 110. GSK Recent Developments
Table 111. Teva Corporation Information
Table 112. Teva Description and Major Businesses
Table 113. Teva Acute Migraine Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 114. Teva Acute Migraine Medications Product
Table 115. Teva Recent Developments
Table 116. Pfizer Corporation Information
Table 117. Pfizer Description and Major Businesses
Table 118. Pfizer Acute Migraine Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 119. Pfizer Acute Migraine Medications Product
Table 120. Pfizer Recent Developments
Table 121. Novartis Corporation Information
Table 122. Novartis Description and Major Businesses
Table 123. Novartis Acute Migraine Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 124. Novartis Acute Migraine Medications Product
Table 125. Novartis Recent Developments
Table 126. Merck Corporation Information
Table 127. Merck Description and Major Businesses
Table 128. Merck Acute Migraine Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 129. Merck Acute Migraine Medications Product
Table 130. Merck Recent Developments
Table 131. Sun Pharma Corporation Information
Table 132. Sun Pharma Description and Major Businesses
Table 133. Sun Pharma Acute Migraine Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 134. Sun Pharma Acute Migraine Medications Product
Table 135. Sun Pharma Recent Developments
Table 136. Grunenthal Corporation Information
Table 137. Grunenthal Description and Major Businesses
Table 138. Grunenthal Acute Migraine Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 139. Grunenthal Acute Migraine Medications Product
Table 140. Grunenthal Recent Developments
Table 141. Endo Pharmaceuticals Corporation Information
Table 142. Endo Pharmaceuticals Description and Major Businesses
Table 143. Endo Pharmaceuticals Acute Migraine Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 144. Endo Pharmaceuticals Acute Migraine Medications Product
Table 145. Endo Pharmaceuticals Recent Developments
Table 146. Key Raw Materials Lists
Table 147. Raw Materials Key Suppliers Lists
Table 148. Acute Migraine Medications Distributors List
Table 149. Acute Migraine Medications Customers List
Table 150. Acute Migraine Medications Market Trends
Table 151. Acute Migraine Medications Market Drivers
Table 152. Acute Migraine Medications Market Challenges
Table 153. Acute Migraine Medications Market Restraints
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Acute Migraine Medications Product Picture
Figure 2. Global Acute Migraine Medications Market Share by Type in 2020 & 2027
Figure 3. Triptans Product Picture
Figure 4. NSAIDs Product Picture
Figure 5. Others Product Picture
Figure 6. Global Acute Migraine Medications Sales Market Share by Application in 2020 & 2027
Figure 7. Drug Stores
Figure 8. Hospital Pharmacies
Figure 9. Acute Migraine Medications Report Years Considered
Figure 10. Global Acute Migraine Medications Sales 2016-2027 (K Units)
Figure 11. Global Acute Migraine Medications Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Acute Migraine Medications Revenue 2016-2027 (US$ Million)
Figure 13. Global Acute Migraine Medications Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Acute Migraine Medications Sales Market Share by Region (2016-2021)
Figure 15. Global Acute Migraine Medications Sales Market Share by Region (2022-2027)
Figure 16. North America Acute Migraine Medications Sales YoY (2016-2027) & (K Units)
Figure 17. North America Acute Migraine Medications Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Acute Migraine Medications Sales YoY (2016-2027) & (K Units)
Figure 19. Europe Acute Migraine Medications Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Acute Migraine Medications Sales YoY (2016-2027) & (K Units)
Figure 21. Asia-Pacific Acute Migraine Medications Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Acute Migraine Medications Sales YoY (2016-2027) & (K Units)
Figure 23. Latin America Acute Migraine Medications Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Acute Migraine Medications Sales YoY (2016-2027) & (K Units)
Figure 25. Middle East & Africa Acute Migraine Medications Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Acute Migraine Medications Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Acute Migraine Medications Revenue in 2020
Figure 28. Acute Migraine Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Acute Migraine Medications Sales Market Share by Type (2016-2027)
Figure 30. Global Acute Migraine Medications Revenue Market Share by Type (2016-2027)
Figure 31. Global Acute Migraine Medications Sales Market Share by Application (2016-2027)
Figure 32. Global Acute Migraine Medications Revenue Market Share by Application (2016-2027)
Figure 33. North America Acute Migraine Medications Sales Market Share by Type (2016-2027)
Figure 34. North America Acute Migraine Medications Revenue Market Share by Type (2016-2027)
Figure 35. North America Acute Migraine Medications Sales Market Share by Application (2016-2027)
Figure 36. North America Acute Migraine Medications Revenue Market Share by Application (2016-2027)
Figure 37. North America Acute Migraine Medications Sales Share by Country (2016-2027)
Figure 38. North America Acute Migraine Medications Revenue Share by Country (2016-2027)
Figure 39. U.S. Acute Migraine Medications Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Acute Migraine Medications Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Acute Migraine Medications Sales Market Share by Type (2016-2027)
Figure 42. Europe Acute Migraine Medications Revenue Market Share by Type (2016-2027)
Figure 43. Europe Acute Migraine Medications Sales Market Share by Application (2016-2027)
Figure 44. Europe Acute Migraine Medications Revenue Market Share by Application (2016-2027)
Figure 45. Europe Acute Migraine Medications Sales Share by Country (2016-2027)
Figure 46. Europe Acute Migraine Medications Revenue Share by Country (2016-2027)
Figure 47. Germany Acute Migraine Medications Revenue (2016-2027) & (US$ Million)
Figure 48. France Acute Migraine Medications Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Acute Migraine Medications Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Acute Migraine Medications Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Acute Migraine Medications Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Acute Migraine Medications Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Acute Migraine Medications Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Acute Migraine Medications Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific Acute Migraine Medications Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific Acute Migraine Medications Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Acute Migraine Medications Revenue Share by Region (2016-2027)
Figure 58. China Acute Migraine Medications Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Acute Migraine Medications Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Acute Migraine Medications Revenue (2016-2027) & (US$ Million)
Figure 61. India Acute Migraine Medications Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Acute Migraine Medications Revenue (2016-2027) & (US$ Million)
Figure 63. Taiwan Acute Migraine Medications Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Acute Migraine Medications Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Acute Migraine Medications Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Acute Migraine Medications Revenue (2016-2027) & (US$ Million)
Figure 67. Philippines Acute Migraine Medications Revenue (2016-2027) & (US$ Million)
Figure 68. Latin America Acute Migraine Medications Sales Market Share by Type (2016-2027)
Figure 69. Latin America Acute Migraine Medications Revenue Market Share by Type (2016-2027)
Figure 70. Latin America Acute Migraine Medications Sales Market Share by Application (2016-2027)
Figure 71. Latin America Acute Migraine Medications Revenue Market Share by Application (2016-2027)
Figure 72. Latin America Acute Migraine Medications Sales Share by Country (2016-2027)
Figure 73. Latin America Acute Migraine Medications Revenue Share by Country (2016-2027)
Figure 74. Mexico Acute Migraine Medications Revenue (2016-2027) & (US$ Million)
Figure 75. Brazil Acute Migraine Medications Revenue (2016-2027) & (US$ Million)
Figure 76. Argentina Acute Migraine Medications Revenue (2016-2027) & (US$ Million)
Figure 77. Middle East and Africa Acute Migraine Medications Sales Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Acute Migraine Medications Revenue Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Acute Migraine Medications Sales Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Acute Migraine Medications Revenue Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Acute Migraine Medications Sales Share by Country (2016-2027)
Figure 82. Middle East and Africa Acute Migraine Medications Revenue Share by Country (2016-2027)
Figure 83. Turkey Acute Migraine Medications Revenue (2016-2027) & (US$ Million)
Figure 84. Saudi Arabia Acute Migraine Medications Revenue (2016-2027) & (US$ Million)
Figure 85. UAE Acute Migraine Medications Revenue (2016-2027) & (US$ Million)
Figure 86. Acute Migraine Medications Value Chain
Figure 87. Acute Migraine Medications Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Keyplayers in Global Acute Migraine Medications Market Insights and Forecast to 2027
GSKTeva
Pfizer
Novartis
Merck
Sun Pharma
Grunenthal
Endo Pharmaceuticals
Request Sample
Request Discount
